Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00973856 · ClinicalTrials.gov registry record · NA
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
A NA study of Warts and Papillomavirus Infections, sponsored by Cleveland Clinic Akron General.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT00973856 is a NA study of Warts and Papillomavirus Infections that has completed, run by Cleveland Clinic Akron General. The registered enrollment target is 5 participants, below the 221-participant average among 7 other Warts trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00973856, a NA study of Warts and Papillomavirus Infections, has completed, sponsored by Cleveland Clinic Akron General.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to conduct a pilot study to determine the effectiveness of PURELL VF481 to treat warts located on the hands.
Conditions Studied
Interventions
- OTHER PURELL VF481
- OTHER Placebo Solution
Study Locations (1)
Ohio
- Akron Dermatology - Akron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00973856
The ClinicalTrials.gov registry entry for NCT00973856 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 7 other Warts trials with a reported enrollment target (98% lower). The listed sponsor is Cleveland Clinic Akron General, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Warts appearing as the primary indexed condition, and to 2 interventions - of which PURELL VF481 is the first listed.
NCT00973856 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00973856 about?
NCT00973856 is a clinical study titled "Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands". The objective is to conduct a pilot study to determine the effectiveness of PURELL VF481 to treat warts located on the hands.
What is the current status of trial NCT00973856?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2009-09. Estimated completion is 2012-01.
What conditions does trial NCT00973856 study?
This clinical trial studies the following conditions: Warts, Papillomavirus Infections, Condylomata Acuminata, Epidermodysplasia Verruciformis.
What interventions are being tested in trial NCT00973856?
The interventions under investigation include: PURELL VF481 (OTHER), Placebo Solution (OTHER).
Who is sponsoring clinical trial NCT00973856?
This trial is sponsored by Cleveland Clinic Akron General, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00973856 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Warts
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Microwave Treatment of Common and Plantar Warts
ACTIVE NOT RECRUITING · NA
-
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
RECRUITING · Phase 1
-
Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
RECRUITING · Phase 2
-
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
RECRUITING
-
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
RECRUITING · Phase 3
-
Candin Safety & Efficacy Study for the Treatment of Warts
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.